IP Verse

B.r.a.h.m.s Gmbh opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Mar 29, 2023

Title:

Proadm As Marker Indicating An Adverse Event

Oppositions:

Patent:

Grant Date:

Mar 30, 2022

Title:

Pct And Pro-Adm As Markers For Monitoring Antibiotic Treatment

Oppositions:

Patent:

Grant Date:

Jul 31, 2019

Title:

Risk Assessment For Antibiotics Treatment In Patients Suffering From Primary Non-Infectious Disease By Determining The Level Of Procalcitonin

Oppositions:

Patent:

Grant Date:

Apr 12, 2017

Title:

Prediction Of Outcome In Patients With Chronic Obstructive Pulmonary Disease

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP3577465	Mar 29, 2023	Proadm As Marker Indicating An Adverse Event	1
EP3682241	Mar 30, 2022	Pct And Pro-Adm As Markers For Monitoring Antibiotic Treatment	1
EP2419741	Jul 31, 2019	Risk Assessment For Antibiotics Treatment In Patients Suffering From Primary Non-Infectious Disease By Determining The Level Of Procalcitonin	1
EP2823314	Apr 12, 2017	Prediction Of Outcome In Patients With Chronic Obstructive Pulmonary Disease	1

DOMPATENT VON KREISLER SELTING WERNER - PARTNERSCHAFT VON PATENTANWALTEN UND RECHTSANWALTEN MBB

RADIOMETER MEDICAL APS

Feel free to send us a message here and we will get back to you